18th Expert Committee: Applications for:
ADDITIONAL FORMULATIONS:
- Chlorhexidine (Change of formulation) -- Children
- Isoniazid + pyridoxine + sulfamethoxazole + trimethoprim (New formulation) -- Adults
- Misoprostol (New formulation) (for specific PPH treatment indication) -- Adults
- Misoprostol (New formulation) (for the prevention of PPH) -- Adults
- Oxytocin (Change of formulation) -- Adults
- Sulfamethoxazole + trimethoprim (New formulation) -- Adults
- Zinc sulfate (New formulation) -- Children
ADDITIONAL MEDICINES:
- Artesunate + amodiaquine fixed-dose combination (Inclusion) -- Adults and Children
- Bisoprolol (Inclusion) -- Adults
- Darunavir (Inclusion) -- Adults and Children
- Dihydroartemisinin + piperaquine (Inclusion) -- Adults and Children
- Etravirine (Inclusion) -- Adults
- Gatifloxacin (Inclusion) -- Adults and Children
- Glucagon (Inclusion) -- Adults and Children
- Imatinib (Inclusion) -- Children and Adolescents
- Loperamide (Inclusion) and codeine phosphate (Deletion) -- Adults
- Midazolam (Inclusion) -- Adults and Children
- Miltefosine (Inclusion) -- Adults and Children
- Paclitaxel and docetaxel (Inclusion) -- Adults
- Propofol (Inclusion) -- Adults
- Pyronaridine + artesunate fixed-dose combination (Inclusion) -- Adults and Children
- Raltegravir (Inclusion) -- Adults
- Tranexamic acid (Inclusion) -- Adults
RE-INSTATEMENT:
POSSIBLE DELETION:
- Antacids and other antiulcer medicines (Deletion) -- Adults and Children
- Codeine (Deletion) -- Children
- DL-methionine (Deletion) -- Adults
- Ethinylestradiol (Deletion) -- Adults
- Loperamide (Inclusion) and codeine phosphate (Deletion) -- Adults
- Medroxyprogesterone acetate (Deletion) -- Adults
- Norethisterone (Deletion) -- Adults
- Promethazine (Deletion) -- Adults and Children
- Salbutamol (Deletion) -- Adults and Children
REVIEW:
- Anaesthesia and muscle relaxant sections (Review) -- Adults and Children
- Antineoplastic, immunosuppressives and medicines used in palliative care (Review) -- Children
- Antithrombotic (Review) -- Children
- Antivirals (Review) -- Adults and Children
- Dermatological medicines (Review) -- Adults and Children
- DMARDs (Review) -- Children
- Fluoroquinolones (Review) -- Children
- Ibuprofen (Review) -- Children
- Mannitol (Review) -- Children
- Neglected tropical diseases (Review) -- Children
- Oral iron chelation therapy (Review) -- Children
- Oral lead chelation therapy (Review) -- Children
- Psychotherapeutic medicines (Review) -- Adults and Children
- Review of the evidence comparing insulin (human or animal) with analogue insulins (Review) -- Adults and Children
- Review of the evidence for H. Pylori treatment regimens: Section 17.1 (Review) -- Adults and Children
- Review of the use of oral hypoglycaemic agents in children (Review) -- Children
- Sodium calcium edetate and penicillamine (Review) --- Children
- Spironolactone (Review) -- Children
- Succimer (Review) -- Children
NEW SECTION:
Contact: emlsecretariat@who.int
Medicine Access and Rational Use (MAR)
20 Avenue Appia
CH-1211 Geneva 27